Photo by Maxim Tolchinskiy on Unsplash
The Historic Appointment of Marcus Lacerda as TDR Director
Marcus Vinícius Guimarães de Lacerda, a distinguished infectious disease specialist and researcher at Fiocruz Amazônia, has been appointed as the new Director of the World Health Organization's (WHO) Special Programme for Research and Training in Tropical Diseases (TDR). This announcement, made by WHO Director-General Tedros Adhanom Ghebreyesus on January 14, 2026, marks a significant moment for global health research, particularly in the realm of neglected tropical diseases (NTDs). Lacerda, who will assume his role in early March 2026, brings decades of frontline experience from the Brazilian Amazon, where tropical diseases pose persistent challenges.
The selection process involved a panel endorsed by TDR's Joint Coordinating Board (JCB) and co-sponsors including UNICEF, the United Nations Development Programme (UNDP), the World Bank, and WHO itself. This appointment underscores Brazil's growing influence in international public health research. As the second Brazilian to lead TDR—following Carlos Morel, a former Fiocruz president—Lacerda's leadership is poised to amplify Fiocruz's global footprint.
Lacerda's journey began in remote Amazonian communities, where he first encountered malaria's devastating impact. His commitment to translating research into actionable health policies has earned him international acclaim, positioning him perfectly to steer TDR's Strategy 2024-2029.
From Brasília to the Amazon: Marcus Lacerda's Remarkable Career Path
Born in Taguatinga near Brasília, Marcus Lacerda earned his medical degree from the University of Brasília (UnB) in 1999. He specialized in infectious diseases at the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD) in Manaus, Amazonas, igniting a lifelong dedication to tropical medicine. Today, he coordinates the Carlos Borborema Clinical Research Institute Laboratory (IPCCB) at Fiocruz's Instituto Leônidas & Maria Deane (ILMD) in Manaus.
Lacerda's academic roles extend beyond Brazil: he is a professor in the Tropical Medicine Graduate Program at the Universidade do Estado do Amazonas (UEA) and an adjunct professor at the University of Texas Medical Branch (UTMB). Previously, he held positions at Kent State University and Tulane University. As former President of the Brazilian Society of Tropical Medicine (SBMT), he has shaped national research agendas.
With over 460 peer-reviewed publications, Lacerda exemplifies the rigorous scholarship essential for advancing higher education and research careers. His work integrates laboratory science, clinical trials, and implementation research, making him a model for aspiring researchers exploring research jobs in higher education.
Photo by Andrea Alama-Powell on Unsplash
Lacerda's Groundbreaking Research at Fiocruz
Fiocruz, Brazil's premier biomedical research institution, has been Lacerda's professional home for over two decades. His research portfolio spans malaria, HIV, histoplasmosis, arboviral diseases like dengue and Zika, snakebite envenoming, and COVID-19. At Fiocruz Amazônia, he has built one of the Amazon's most advanced clinical research centers, blending cutting-edge diagnostics with policy-informing trials.
A highlight is his leadership in implementing tafenoquine, the first single-dose radical cure for Plasmodium vivax malaria in 40 years. This breakthrough, now embedded in WHO malaria treatment guidelines, stemmed from collaborative trials that bridged academia, industry, and public health systems. Lacerda also pioneered oral and injectable pre-exposure prophylaxis (PrEP) for HIV and minimally invasive tissue sampling (MITS) for post-mortem analysis in the Amazon.
Currently, he leads the Telemal project, leveraging telemedicine to deliver rapid malaria diagnostics and treatments to remote areas. These innovations highlight Fiocruz's role in fostering research excellence, inspiring careers in research assistant positions and beyond.
Photo by Angels for Humanity on Unsplash
Revolutionizing Malaria Research: Focus on Plasmodium vivax
Malaria remains a scourge in Brazil, with the Amazon accounting for over 99% of cases. Lacerda's expertise in P. vivax—responsible for 70-80% of Amazonian malaria—has transformed elimination strategies. Unlike P. falciparum, P. vivax forms dormant liver stages (hypnozoites), complicating eradication.
Step-by-step, his approach involves: (1) advanced genotyping to track relapse vs. reinfection; (2) clinical trials for tafenoquine safety in G6PD-deficient populations; (3) implementation studies scaling treatments regionally; and (4) policy advocacy integrating findings into Brazil's National Malaria Control Program.
His publications in top journals like The Lancet and New England Journal of Medicine have garnered thousands of citations, solidifying his status as a leader. For researchers eyeing postdoctoral opportunities, Lacerda's trajectory offers invaluable lessons in impactful science.
Photo by Jacinto Diego on Unsplash
Facing Adversity: Lacerda's COVID-19 Research Amid Political Turmoil
During Brazil's COVID-19 crisis, Lacerda led rigorous trials disproving hydroxychloroquine's efficacy, defying then-President Jair Bolsonaro's promotion of the drug. His 2020 study in Manaus, halted early due to cardiac risks in high-dose arms, drew global attention but sparked threats and persecution from supporters.
Undeterred, Lacerda's team advanced evidence-based responses, including variant surveillance in the Amazon. This resilience amid politicized science underscores the challenges—and fortitude—required in public health research, a stark reminder for those pursuing academic careers.
Photo by Mufid Majnun on Unsplash
Understanding TDR: WHO's Cornerstone for NTD Research
The Special Programme for Research and Training in Tropical Diseases (TDR), established in 1975, drives R&D for NTDs affecting over 1.7 billion people in low- and middle-income countries (LMICs). Co-sponsored by multiple UN agencies, TDR emphasizes capacity building, product development, and implementation research using a One Health approach.
Key achievements include vaccines for leishmaniasis, new diagnostics for Chagas disease, and strategies eliminating onchocerciasis in parts of Latin America. Under Lacerda, TDR will prioritize translating evidence into sustainable health systems. Learn more via the TDR WHO website.
The Burden of Neglected Tropical Diseases in Brazil and Beyond
Brazil grapples with nine WHO-defined NTDs: Chagas disease, dengue, leishmaniasis, schistosomiasis, trachoma, and others. In 2016, they caused 475,410 disability-adjusted life years (DALYs), though rates fell 45.7% from 1990 levels. Latin America bears 8.8% of global NTD DALYs, with Brazil leading research output.
- Dengue: Over 3 million cases annually, straining health systems.
- Chagas: Affects 6-7 million in LAC, Fiocruz pivotal in diagnostics.
- Leishmaniasis: Urbanization fuels visceral cases in Brazil.
Fiocruz's contributions, amplified by Lacerda's networks, position Brazil centrally. For detailed stats, see the WHO Global Report on NTDs 2025.
Photo by Mufid Majnun on Unsplash
Implications for Brazil's Research Ecosystem and Fiocruz
Lacerda's appointment elevates Fiocruz's profile, fostering collaborations on dengue trials slated for Brazil in 2026 and Chagas innovations. It signals opportunities for Brazilian universities and researchers in global consortia, enhancing funding via CNPq and international grants.
Stakeholders praise the move: Quique Bassat of ISGlobal called Lacerda a "global health giant." This boosts morale post-pandemic challenges, encouraging enrollment in tropical medicine graduate programs at institutions like UEA.
Photo by Juan Fernández on Unsplash
Future Outlook: Lacerda's Vision for TDR Strategy 2024-2029
Lacerda vows to advance TDR's goals: strengthening local leadership, building resilient systems, and prioritizing high-need areas. Expect emphasis on AI-driven diagnostics, equitable access to tafenoquine-like innovations, and Amazon-centric models scalable to Africa and Asia.
Challenges include funding gaps and climate-driven disease spread, but opportunities abound in cross-sector partnerships. Researchers can prepare via clinical research jobs and Fiocruz training.
Photo by soula walid on Unsplash
Career Pathways in Tropical Diseases Research Inspired by Lacerda
Lacerda's ascent inspires higher ed professionals. Key steps: (1) Build interdisciplinary expertise (medicine + public health); (2) Publish prolifically; (3) Engage in implementation research; (4) Network globally via SBMT or WHO panels.
- University jobs in Brazil's top institutions like UnB or UEA.
- Postdoc roles at Fiocruz or UTMB for hands-on trials.
- Professor positions emphasizing NTDs amid rising demand.
Explore openings at AcademicJobs.com higher ed jobs or Brazil university listings.
A New Chapter for Global Tropical Medicine Research
Marcus Lacerda's TDR directorship heralds a vibrant era for NTD research, leveraging Brazil's strengths for worldwide impact. As Fiocruz continues innovating, professionals are urged to pursue passions in this vital field. Check Rate My Professor for insights on tropical medicine faculty, higher ed jobs for openings, and career advice to chart your path. Share your thoughts below.
